Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- NUDGE-EHRIndependent statistical analysis of NUDGE-EHR Replication Trial at Mass General Brigham: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05538065).
- NUDGE-EHRIndependent statistical analysis of Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nudges and Incentives to Enhance the Opioid Treatment Workforce: Complete Statistical AnalysisIndependent statistical analysis of Nudges and Incentives to Enhance the Opioid Treatment Workforce: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03834025).
- Nudging Provider Adoption of Clinical Decision Support: Complete Statistical AnalysisIndependent statistical analysis of Nudging Provider Adoption of Clinical Decision Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05203185).
- NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: Complete Statistical AnalysisIndependent statistical analysis of NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669785).
- Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: Complete Statistical AnalysisIndependent statistical analysis of Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT: primary endpoint results, effect estimate with confidence interval, sample-size…
- Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: Complete Statistical AnalysisIndependent statistical analysis of Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435265).
- Nurse Initiated Acupressure for Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Nurse Initiated Acupressure for Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044716).
- Nurse-Led Interprofessional Mental Health Promotion Intervention for Older Home Care Clients: Complete Statistical AnalysisIndependent statistical analysis of Nurse-Led Interprofessional Mental Health Promotion Intervention for Older Home Care Clients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nurse-led Medicines’ Monitoring in Care Homes: a Process Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03110471).
- NURTUREIndependent statistical analysis of A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy: primary endpoint results, effect estimate with confidence interval,…
- NURTURE 1Independent statistical analysis of Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis…
- Nutraceutical Efficacy for rUTI: Complete Statistical AnalysisIndependent statistical analysis of Nutraceutical Efficacy for rUTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395288).
- Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children: Complete Statistical AnalysisIndependent statistical analysis of Nutricity: An mHealth Nutrition Intervention to Improve Diet Quality Among Latino Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nutrition Monitoring and Feeding Optimization With the smART+ System – Comparative Study: Complete Statistical AnalysisIndependent statistical analysis of Nutrition Monitoring and Feeding Optimization With the smART+ System - Comparative Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: Complete Statistical AnalysisIndependent statistical analysis of Nutritional Education and the Prevention of Iron Depletion in Children 9 Months to 2 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NVA237 BID Versus Placebo Twelve-week Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of NVA237 BID Versus Placebo Twelve-week Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01715298).
- NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine: Complete Statistical AnalysisIndependent statistical analysis of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00199849).
- O-BMTIndependent statistical analysis of Onsite Buprenorphine Treatment at Syringe Exchange Programs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03150173).
- OA CAREIndependent statistical analysis of OA Clinic-Community CARE Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05349500).
- OA-PCPIndependent statistical analysis of Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OAKIndependent statistical analysis of Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- OARS-PilotIndependent statistical analysis of Opioid Analgesic Reduction Study (OARS) - Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05283499).
- OARSCMIndependent statistical analysis of Reward-based Technology to Improve OUD Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05180669).
- OASISIndependent statistical analysis of Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04720664).
- OASISIndependent statistical analysis of Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- OASISIndependent statistical analysis of BlueWind RENOVA iStim™ System for the Treatment of OAB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03596671).
- OASISIndependent statistical analysis of Global Sinus Surgery Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02347943).
- OASIS 2Independent statistical analysis of Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity: primary endpoint results, effect estimate…
- OASIS Wound Matrix (Oasis) Mechanism of Action: Complete Statistical AnalysisIndependent statistical analysis of OASIS Wound Matrix (Oasis) Mechanism of Action: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570141).
- OASIS-1Independent statistical analysis of A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal…
- OASIS-4Independent statistical analysis of A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy…
- OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): primary endpoint results, effect estimate with confidence…
- OASIS(CM)Independent statistical analysis of Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OATIndependent statistical analysis of Oral Anticoagulation Therapy Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01959425).
- Obatoclax for Systemic Mastocytosis: Complete Statistical AnalysisIndependent statistical analysis of Obatoclax for Systemic Mastocytosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00918931).
- Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval,…
- ObePso-SIndependent statistical analysis of Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients: primary endpoint results, effect estimate with confidence interval, sample-size…
- OBERALIndependent statistical analysis of Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Obesity and Nonalcoholic Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Obesity and Nonalcoholic Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00262964).
- Obesity, Sleep Apnea, and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Obesity, Sleep Apnea, and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02192684).
- Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma: Complete Statistical AnalysisIndependent statistical analysis of Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery Interventions: Complete Statistical AnalysisIndependent statistical analysis of Observational Clinical Study to Plan, Position and Check Instrument Placement for Spine Surgery Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Observational Data Analysis in EuroSIDA (MK-0518-058): Complete Statistical AnalysisIndependent statistical analysis of Observational Data Analysis in EuroSIDA (MK-0518-058): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01078233).
- Observational Examination of Thermoregulation in Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Observational Examination of Thermoregulation in Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02225743).
- Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.: Complete Statistical AnalysisIndependent statistical analysis of Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00531206).
- Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis: Complete Statistical AnalysisIndependent statistical analysis of Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study): Complete Statistical AnalysisIndependent statistical analysis of Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema: Complete Statistical AnalysisIndependent statistical analysis of Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…